Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 23.39
-2.74 %
$ 1.08 B
Market Cap
-10.88
P/E
PCRX - COST OF REVENUE
Cost of Revenue PCRX - Pacira BioSciences, Inc.
185 M
LAST VALUE
14.75%
2 YEAR CAGR
16.29%
5 YEAR CAGR
12.92%
10 YEAR CAGR